Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marsha Y Morgan

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
The Cochrane Database of Systematic Reviews|October 30, 2018
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varicesAntony P Zacharias, Rebecca Jeyaraj, Lise Hobolth, et al.
Bioscience Reports|April 15, 2020
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastasesHaarith Ndiaye, Jorlin Y Liu, Andrew Hall, et al.
The Cochrane Database of Systematic Reviews|July 19, 2023
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosisHarry D Zacharias, Fady Kamel, Jaclyn Tan, et al.
The Cochrane Database of Systematic Reviews|February 3, 2026
Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathyRebecca Jeyaraj, Harry D Zacharias, Sonam Vadera, et al.
Pharmacoeconomics|April 9, 2015
Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, John W Stevens, et al.
Metabolic Brain Disease|September 12, 2007
The treatment of hepatic encephalopathyMarsha Y Morgan, A Blei, K Grüngreiff, et al.
The Cochrane Database of Systematic Reviews|May 16, 2018
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosisEe Teng Goh, Caroline S Stokes, Sandeep S Sidhu, et al.
Risk Management and Healthcare Policy|March 14, 2024
Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?Obinna O Oleribe, Andrew W Taylor-Robinson, Okey C Nwanyanwu, et al.
European Journal of Gastroenterology & Hepatology|January 16, 2010
Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two casesMikio Kajihara, Sara Montagnese, Pooja Khanna, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatmentSara Montagnese, Harriet M Gordon, Clive Jackson, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
The Cochrane Database of Systematic Reviews|October 30, 2018
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varicesAntony P Zacharias, Rebecca Jeyaraj, Lise Hobolth, et al.
Bioscience Reports|April 15, 2020
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastasesHaarith Ndiaye, Jorlin Y Liu, Andrew Hall, et al.
The Cochrane Database of Systematic Reviews|July 19, 2023
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosisHarry D Zacharias, Fady Kamel, Jaclyn Tan, et al.
The Cochrane Database of Systematic Reviews|February 3, 2026
Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathyRebecca Jeyaraj, Harry D Zacharias, Sonam Vadera, et al.
Pharmacoeconomics|April 9, 2015
Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, John W Stevens, et al.
Metabolic Brain Disease|September 12, 2007
The treatment of hepatic encephalopathyMarsha Y Morgan, A Blei, K Grüngreiff, et al.
The Cochrane Database of Systematic Reviews|May 16, 2018
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosisEe Teng Goh, Caroline S Stokes, Sandeep S Sidhu, et al.
Risk Management and Healthcare Policy|March 14, 2024
Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?Obinna O Oleribe, Andrew W Taylor-Robinson, Okey C Nwanyanwu, et al.
European Journal of Gastroenterology & Hepatology|January 16, 2010
Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two casesMikio Kajihara, Sara Montagnese, Pooja Khanna, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatmentSara Montagnese, Harriet M Gordon, Clive Jackson, et al.
Pageof 9